Department of Health and Social Care (DHSC) has issued a medicine supply notification for Hyoscine hydrobromide (Kwells Kids®)150mcg and (Kwells®) 300mcg tablets
Tier 2 – medium impact
Date of issue 3rd February 2023
Hyoscine hydrobromide (Kwells Kids®) 150mcg and (Kwells®) 300mcg tablets are out of stock until 15th February 2023.
Alternative products remain available for indications covered by hyoscine hydrobromide.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Hyoscine hydrobromide (Kwells Kids®)150mcg and (Kwells®) 300mcg tablets appeared first on PSNC Website.